Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$13.89	$10.93	$8.80 ▼ $32.71	$618.96M	3.4	738,198 shs	1.01 million shs
CLPT ClearPoint Neuro	$12.89 -10.0%	$11.04	$8.27 ▼ $30.10	$429.45M	1.31	683,065 shs	625,013 shs
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$464.90M	1.03	141,467 shs	83,242 shs
MBOT Microbot Medical	$1.84 -6.1%	$2.14	$1.60 ▼ $4.67	$131.64M	1.04	2.06 million shs	870,503 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+11.60%	+14.79%	+38.76%	+30.91%	-28.59%
CLPT ClearPoint Neuro	+7.67%	+16.99%	+29.01%	+43.20%	+10.24%
KIDS OrthoPediatrics	+6.97%	+1.63%	+6.22%	+0.28%	-10.04%
MBOT Microbot Medical	-0.51%	+1.55%	-6.67%	-17.65%	-28.99%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$13.89	$10.93	$8.80 ▼ $32.71	$618.96M	3.4	738,198 shs	1.01 million shs
CLPT ClearPoint Neuro	$12.89 -10.0%	$11.04	$8.27 ▼ $30.10	$429.45M	1.31	683,065 shs	625,013 shs
KIDS OrthoPediatrics	$18.32 +1.2%	$16.89	$14.42 ▼ $23.70	$464.90M	1.03	141,467 shs	83,242 shs
MBOT Microbot Medical	$1.84 -6.1%	$2.14	$1.60 ▼ $4.67	$131.64M	1.04	2.06 million shs	870,503 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+11.60%	+14.79%	+38.76%	+30.91%	-28.59%
CLPT ClearPoint Neuro	+7.67%	+16.99%	+29.01%	+43.20%	+10.24%
KIDS OrthoPediatrics	+6.97%	+1.63%	+6.22%	+0.28%	-10.04%
MBOT Microbot Medical	-0.51%	+1.55%	-6.67%	-17.65%	-28.99%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.64	Moderate Buy	$19.70	41.83% Upside
CLPT ClearPoint Neuro	2.33	Hold	$18.00	39.64% Upside
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	33.43% Upside
MBOT Microbot Medical	2.60	Moderate Buy	$6.63	260.05% Upside

Current Analyst Ratings Breakdown

Latest MBOT, BBNX, KIDS, and CLPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/3/2026	MBOT Microbot Medical	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$4.00
5/27/2026	BBNX Beta Bionics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$19.00 ➝ $17.00
5/18/2026	BBNX Beta Bionics	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$23.00 ➝ $11.00
5/8/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/22/2026	BBNX Beta Bionics	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$25.00 ➝ $24.00
4/22/2026	BBNX Beta Bionics	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$22.00 ➝ $20.00
4/21/2026	BBNX Beta Bionics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$100.25M	6.17	N/A	N/A	$6.53 per share	2.13
CLPT ClearPoint Neuro	$36.97M	10.46	N/A	N/A	$0.99 per share	13.02
KIDS OrthoPediatrics	$236.35M	1.99	$0.17 per share	108.85	$13.82 per share	1.33
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.15 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$73.20M	-$1.51	N/A	N/A	N/A	-60.27%	-23.00%	-20.55%	N/A
CLPT ClearPoint Neuro	-$25.54M	-$1.01	N/A	N/A	N/A	-71.57%	-140.96%	-36.98%	8/11/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)
MBOT Microbot Medical	-$13.14M	-$0.26	N/A	N/A	N/A	N/A	-21.84%	-20.71%	8/11/2026 (Estimated)

Latest MBOT, BBNX, KIDS, and CLPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2026	Q1 2026	CLPT ClearPoint Neuro	-$0.28	-$0.32	-$0.04	-$0.32	$11.97 million	$12.13 million
5/13/2026	Q1 2026	MBOT Microbot Medical	-$0.08	-$0.05	+$0.03	-$0.05	$0.30 million	$0.11 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
4/21/2026	Q1 2026	BBNX Beta Bionics	-$0.53	-$0.49	+$0.04	-$0.49	N/A	$27.63 million
3/27/2026	Q4 2025	MBOT Microbot Medical	-$0.06	-$0.04	+$0.02	-$0.04	$0.11 million	N/A
3/17/2026	Q4 2025	CLPT ClearPoint Neuro	-$0.22	-$0.27	-$0.05	-$0.27	$10.40 million	$10.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	10.69	9.67
CLPT ClearPoint Neuro	2.63	5.79	4.88
KIDS OrthoPediatrics	0.29	5.21	2.37
MBOT Microbot Medical	0.01	22.59	21.93

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
CLPT ClearPoint Neuro	30.08%
KIDS OrthoPediatrics	69.05%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	5.30%
CLPT ClearPoint Neuro	6.94%
KIDS OrthoPediatrics	32.70%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	44.56 million	42.20 million	N/A
CLPT ClearPoint Neuro	110	29.99 million	27.91 million	Optionable
KIDS OrthoPediatrics	200	25.68 million	17.29 million	Optionable
MBOT Microbot Medical	20	67.17 million	63.98 million	Optionable

MBOT, BBNX, KIDS, and CLPT Headlines

Recent News About These Companies

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

June 2 at 8:30 AM | globenewswire.com

Microbot Medical Draws Attention Amid Healthcare Stock Growth

May 31, 2026 | kalkinemedia.comK

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

May 26, 2026 | globenewswire.com

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)

May 19, 2026 | zacks.com

Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript

May 19, 2026 | seekingalpha.com

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic ...

May 15, 2026 | markets.businessinsider.com

Microbot Medical Inc. to Host Conference Call Addressing Misrepresentations from Unaffiliated Third-Party Article

May 15, 2026 | quiverquant.comQ

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu

May 15, 2026 | globenewswire.com

Microbot Medical Affirms Stability, Advances LIBERTY U.S. Launch

May 14, 2026 | theglobeandmail.com

Microbot Medical stock drops after White Diamond short report

May 14, 2026 | investing.com

Microbot Medical plunges amid results, short report from White Diamond Research

May 14, 2026 | msn.com

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

May 14, 2026 | globenewswire.com

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates

May 13, 2026 | zacks.com

Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday

May 6, 2026 | marketbeat.com

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

May 5, 2026 | markets.businessinsider.com

Microbot Medical®'s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

May 5, 2026 | globenewswire.com

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

April 30, 2026 | globenewswire.com

Stryker to Report Q1 Earnings: What's in Store for the Stock?

April 28, 2026 | zacks.com

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

April 22, 2026 | globenewswire.com

Microbot Medical Begins Full U.S. Launch of LIBERTY System

April 15, 2026 | zacks.com

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) ...

April 14, 2026 | caledonianrecord.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, BBNX, KIDS, and CLPT Company Descriptions

Beta Bionics NASDAQ:BBNX

$13.89 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$13.99 +0.10 (+0.72%)

As of 07:01 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

ClearPoint Neuro NASDAQ:CLPT

$12.89 -1.43 (-9.99%)

Closing price 04:00 PM Eastern

Extended Trading

$12.80 -0.09 (-0.67%)

As of 07:55 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

OrthoPediatrics NASDAQ:KIDS

$18.32 +0.22 (+1.22%)

Closing price 04:00 PM Eastern

Extended Trading

$18.34 +0.02 (+0.11%)

As of 05:55 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Microbot Medical NASDAQ:MBOT

$1.84 -0.12 (-6.12%)

Closing price 04:00 PM Eastern

Extended Trading

$1.82 -0.02 (-1.09%)

As of 07:49 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, BBNX, KIDS, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, BBNX, KIDS, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, BBNX, KIDS, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, BBNX, KIDS, and CLPT Company Descriptions

Beta Bionics NASDAQ:BBNX

ClearPoint Neuro NASDAQ:CLPT

OrthoPediatrics NASDAQ:KIDS

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, BBNX, KIDS, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, BBNX, KIDS, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, BBNX, KIDS, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, BBNX, KIDS, and CLPT Company Descriptions

Beta Bionics NASDAQ:BBNX

ClearPoint Neuro NASDAQ:CLPT

OrthoPediatrics NASDAQ:KIDS

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools